Anteris Technologies Global Corp. AVR
5.69 USD +0.11 (+1.97%)
At closeNov 6, 2026, 7:56 PM EST
5.75 +0.06 +1.05%
After hours · Nov 6, 7:56 PM ET
5.47 Day range 5.79
3.38 52-week range 10.57
- YTD
- +14.03%
- 1 year
- +41.19%
- Market cap
- 553.88M
- Revenue (ttm)
- 1.85M
- EPS (ttm)
- -1.95
- Shares out
- 97.34M
- Forward P/E
- -10.79
- YTD return
- +14.03%
- 1-year return
- +41.19%
- Volume
- 1.22M
- Avg volume
- 1.12M
- Open
- 5.55
- Previous close
- 5.58
- Day's range
- 5.47 – 5.79
- 52-week range
- 3.38 – 10.57
- Beta
- 0.73
- Analysts
- Strong Buy
- Price target
- 15.33 (+169.5%)
- Earnings date
- Aug 14, 2026
1Y +1.71 (+42.96%)
Key statistics
- Enterprise value
- 717.79M
- PEG ratio
- 0.00
- Price / sales
- 555.87
- Price / book
- 3.69
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- -11.20%
- Free cash flow
- -52.66M
- Total cash
- 282.70M
- Total debt
- 3.73M
- Return on equity
- -59.21%
- Short % of float
- 8.34%
- 50-day average
- 8.23
- 200-day average
- 5.95
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 15.33 +169.5% upside
Now 5.69
- Target (low)
- 15.00
- Target (mean)
- 15.33
- Target (high)
- 16.00
Ratings (0m) 3 3 buy · 0 hold · 0 sell
- Strong buy0
- Buy3
- Hold0
- Sell0
- Strong sell0
Next earnings
Aug 14, 2026
Expected Aug 14, 2026. Consensus EPS estimate -0.20667.
Financials — quick view
AVR Revenue — quarterly 1.01M
AVR Net income — quarterly -29.09M
AVR EPS — quarterly -0.30
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Aug 14, 2026 | Jun 30, 2026 | -0.2073 | — | — | — |
| May 12, 2026 | Mar 31, 2026 | -0.2073 | -0.28 | -0.07 | -35.07% |
| Mar 11, 2026 | Dec 31, 2025 | -0.27083 | -0.74 | -0.47 | -173.23% |
| Nov 10, 2025 | Sep 30, 2025 | -0.54233 | -0.62 | -0.08 | -14.32% |
| Aug 12, 2025 | Jun 30, 2025 | -0.545 | -0.58 | -0.03 | -6.42% |
| May 13, 2025 | Mar 31, 2025 | -0.53333 | -0.61 | -0.08 | -14.38% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| May 15, 2026 | Barclays | main | Overweight | Overweight |
| Mar 27, 2026 | Cantor Fitzgerald | reit | Overweight | Overweight |
| Mar 11, 2026 | Wells Fargo | init | — | Overweight |
| Jan 8, 2025 | Lake Street | init | — | Buy |
| Jan 7, 2025 | TD Cowen | init | — | Buy |
| Jan 7, 2025 | Cantor Fitzgerald | init | — | Overweight |
About Anteris Technologies Global Corp.
Anteris Technologies Global Corp., a structural heart company, develops and commercializes minimally invasive medical devices to treat heart valve diseases. It offers the DurAVR transcatheter heart valve system, a novel transcatheter aortic valve for the treatment of severe aortic stenosis that is shaped to mimic the performance of a healthy human aortic valve. The company also develops ADAPT anti-calcification tissue, an anti-calcification preparation which transforms xenograft tissue into durable bioscaffolds that are used to mimic human tissue for surgical repair in multiple settings, including aortic valve replacement; and ComASUR delivery system, a physician-developed balloon expandable delivery system that contains a reinforced steerable catheter for a precise deflection through the heart anatomy in a controlled manner to avoid damage to the aorta. Anteris Technologies Global Corp. is based in Toowong, Australia.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Country
- Australia
- Website
- anteristech.com
News
Anteris Reports Medium-Size DurAVR THV Outcomes from the EMBARK Study at TCT 2026 
Anteris Technologies To Present First 30-Day Clinical And Hemodynamic Outcomes For Its Medium-Size DurAVR Transcatheter Heart Valve At The Transcatheter Cardiovascular Therapeutics Conference, October 31-November 3 
Cantor Fitzgerald Reiterates Overweight on Anteris Technologies Glb, Maintains $15 Price Target 
Why Enovix Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket 
Barclays Initiates Coverage On Anteris Technologies Glb with Equal-Weight Rating, Announces Price Target of $10 - Cantor Fitzgerald Reiterates Overweight on Anteris Technologies Glb, Maintains $15 Price Target
- Reported Earlier, Anteris Technologies Glb Q2 EPS $(0.30) Misses $(0.21) Estimate, Sales $1.009M Miss $1.500M Estimate
12 Health Care Stocks Moving In Friday's Pre-Market Session 
Porch Group, Micron And Other Big Stocks Moving Lower In Monday’s Pre-Market Session 
Anteris Technologies Receives Full Regulatory Clearance From The French National Agency For Medicines And Health Products Safety For The DurAVR Transcatheter Heart Valve Global Pivotal Trial In Patients With Severe Calcific Aortic Stenosis
Your note
Sign in to keep a note on AVR — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| DENARO STEPHEN | Director | Conversion of Exercise of derivative security | Mar 10, 2025 | 0 |
| KNIGHT SUSAN ELIZABETH | Director | Purchase | Jun 1, 2026 | 11,000 |
| L1 CAPITAL PTY. LTD. | Beneficial Owner of more than 10% of a Class of Security | Purchase | Jan 21, 2026 | 0 |
| MCDONNELL MATTHEW | Chief Financial Officer | Conversion of Exercise of derivative security | Jun 4, 2026 | 0 |
| MOSS GREGORY S. ESQ. | Director | Conversion of Exercise of derivative security | Jun 4, 2026 | 17,580 |
| PATERSON WAYNE | Chief Executive Officer | Conversion of Exercise of derivative security | Dec 15, 2025 | 0 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| L1 Capital Pty Ltd | 8.00% | 7,789,000 | 82.33M | Mar 30, 2026 |
| Nantahala Capital Management, LLC | 5.68% | 5,530,910 | 58.46M | Mar 30, 2026 |
| Sio Capital Management, LLC | 5.53% | 5,382,965 | 56.90M | Mar 30, 2026 |
| Blackrock Inc. | 5.02% | 4,889,153 | 51.68M | Mar 30, 2026 |
| Adar1 Capital Management, LLC | 3.89% | 3,789,132 | 40.05M | Mar 30, 2026 |
| Perceptive Advisors Llc | 3.52% | 3,425,476 | 36.21M | Mar 30, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| iShares Trust-iShares Russell 2000 ETF | 1.90% | 1,849,589 | 19.55M | Apr 29, 2026 |
| Fidelity Investment Trust-Fidelity Pacific Basin Fund | 1.84% | 1,795,137 | 18.97M | May 30, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 0.88% | 857,279 | 9.06M | Mar 30, 2026 |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 0.81% | 785,732 | 8.31M | Apr 29, 2026 |
| iShares Trust-iShares Russell 2000 Growth ETF | 0.66% | 643,786 | 6.80M | Apr 29, 2026 |
| Fidelity Investment TRT-Fidelity Intl Small Cap Opportunities Fd. | 0.46% | 449,000 | 4.75M | Apr 29, 2026 |